Dec
06

Both sides hint at renewed 'fiscal cliff' talks

0 comments
WASHINGTON (Reuters) - With little to show after a month of posturing, the White House and Republicans in Congress dropped hints on Thursday that they had resumed low-level private talks on breaking the stalemate over the "fiscal cliff" but refused to divulge details. A day after a phone conversation between President Barack Obama and John Boehner, the Republican speaker of the House...
Read More..
Dec
05

Death toll from Philippine typhoon nears 300

0 comments
NEW BATAAN, Philippines (AP) — Stunned parents searching for missing children examined a row of mud-stained bodies covered with banana leaves while survivors dried their soaked belongings on roadsides Wednesday, a day after a powerful typhoon killed nearly 300 people in the southern Philippines.Officials fear more bodies may be found as rescuers reach hard-hit areas that were isolated by landslides,...
Read More..

Casio’s new G-Shock smartwatch can display alerts from your iPhone [video]

0 comments
Since the Dick Tracy cartoon days, every gadget nerd’s dream has been to have a smartwatch. And while smartphones have largely made the need for wearing wristwatches unnecessary, companies continue to search for ways to connect watches and smartphones. Casio’s GB6900AA G-Shock is the latest smartwatch that connects to Apple (AAPL) iPhone 4S and iPhone 5. Using Bluetooth 4.0, the watch can provide...
Read More..

Grammys spread the love with 6 top nominees

0 comments
NASHVILLE, Tenn. (AP) — The Grammy Awards celebrated the diversity of music as six different artists tied for lead nominee — Kanye West, Jay-Z, Frank Ocean, Dan Auerbach of The Black Keys, Mumford & Sons and fun.Auerbach received five nominations as a member of the Keys and also is up for producer of the year, earning a spot with the others at the top of the list as the Grammy’s primetime television...
Read More..

Pfizer breast cancer drug delays progression 18 months

0 comments
(Reuters) – An experimental drug showed impressive effectiveness and safety in a mid-stage trial against a common form of advanced breast cancer, lifting Pfizer Inc shares nearly 2 percent.The favorable results prompted the drugmaker to plan large late-stage trials of the drug next year. If approved, the medicine could fetch multi-billion dollar sales, industry analysts said.The drug, called PD-0332991,...
Read More..

Syria loads chemical weapons, waits for green light

0 comments
U.S. Secretary of State Hillary Clinton attends the "Friends of Syria" confernence in Paris. (AP)U.S. officials say the Syrian military has loaded active chemical weapons into bombs and is awaiting a final order from embattled President Bashar Assad to use the deadly weapons against its own people.NBC News reports that on Wednesday the Syrian military loaded sarin gas into aerial bombs that could...
Read More..
Dec
04

WestJet embraces tech to woo business travelers

0 comments
TORONTO (Reuters) – WestJet Airlines Ltd will use technological innovation, including a new Internet ticket booking system, to help it transform from a no-frills carrier to a lower-cost full-service airline courting lucrative corporate travelers, its chief executive said on Monday.Canada’s second-biggest airline plans to launch a series of technology systems, most notably the new online booking engine,...
Read More..

HTC, Apple ordered to show which patents were included in their settlement agreement

0 comments
...
Read More..

Netflix to get Disney films in TV distribution deal

0 comments
(Reuters) – Walt Disney gave a much needed boost to Netflix, becoming the first major Hollywood studio to use the video service to bypass premium channels like HBO that traditionally controlled the delivery of movies to TV subscribers.News of the deal, which enables Netflix to stream Disney‘s first-run movies to its subscribers, boosted Netflix shares by 14 percent.Liberty Media Corp, whose Starz...
Read More..

Chelsea’s hypotension drug fails to prove efficacy past week one

0 comments
(Reuters) – Chelsea Therapeutics Inc said its experimental hypotension drug met the main goal of a study by significantly reducing dizziness in patients at week one, but results beyond that period were not statistically significant.The U.S. Food and Drug Administration declined to approve the drug, Northera, in March, and asked for data that proved it was effective over two to three months.The company’s...
Read More..